Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from OncoSil Medical Ltd ( (AU:OSL) ) is now available.
OncoSil Medical Ltd has addressed an inquiry from the ASX regarding the late submission of an Appendix 3X document, which is linked to a director’s interest notice. The delay was attributed to an administrative oversight, and measures are in place to prevent future occurrences. The company believes its current disclosure arrangements are adequate, but the late lodging has been communicated to the board and relevant staff to ensure compliance with ASX listing rules.
More about OncoSil Medical Ltd
OncoSil Medical Ltd is a company in the medical industry, focused on providing innovative solutions for cancer treatment. It operates with a specific focus on developing and commercializing medical devices designed for the treatment of pancreatic and other cancers.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$32.25M
For a thorough assessment of OSL stock, go to TipRanks’ Stock Analysis page.
